Author:
Poulin Patrick,Jones Hannah M.,Jones Rhys Do,Yates James W.T.,Gibson Christopher R.,Chien Jenny Y.,Ring Barbara J.,Adkison Kimberly K.,He Handan,Vuppugalla Ragini,Marathe Punit,Fischer Volker,Dutta Sandeep,Sinha Vikash K.,Björnsson Thorir,Lavé Thierry,Sherry Ku M.
Reference47 articles.
1. Food and Drug Administration (FDA).2002 Estimating the safe starting dose in clinical trials for therapeutics in adult healthyvolunteers. Guidance for industry Rockville, Maryland. Available at: http://www.fda.gov/cder/guidance/index.htm
2. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers,2005
3. S9 non clinical evaluation for anticancer pharmaceuticals,2010
4. Pharmacologically guided phase I clinical trials based upon preclinical drug development;Collins;J Natl Cancer Inst,1990
5. First-time-in-human dose selection: Allometric thoughts and perspectives;Boxenbaum;J Clin Pharmacol,1995
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献